- Home
- IAS vs ALVO Comparison
IAS vs ALVO Comparison
Compare IAS & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IAS | ALVO |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | IAS | ALVO |
|---|---|---|
| Price | $10.28 | $5.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $12.02 | $10.67 |
| AVG Volume (30 Days) | ★ 1.3M | 820.8K |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.72 | N/A |
| EPS | ★ 0.28 | 0.24 |
| Revenue | ★ $590,666,000.00 | $573,350,000.00 |
| Revenue This Year | $14.72 | $34.94 |
| Revenue Next Year | $11.34 | $39.55 |
| P/E Ratio | $36.80 | ★ $21.24 |
| Revenue Growth | 15.51 | ★ 45.55 |
| 52 Week Low | $6.26 | $4.70 |
| 52 Week High | $11.78 | $13.70 |
Technical Indicators
Market Signals| Indicator | IAS | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 63.65 | 33.90 |
| Support Level | $10.21 | $5.05 |
| Resistance Level | $10.29 | $5.49 |
| Average True Range (ATR) | 0.03 | 0.28 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 81.25 | 6.87 |
Price Performance
Historical ComparisonAbout IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.